<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000658047">
  <TermName>poly (ADP-ribose) polymerase</TermName>
  <TermPronunciation>(PAH-lee (... RY-bose) puh-LIH-meh-rays)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>  A type of enzyme involved in many functions of the cell, including the repair of DNA damage. DNA damage may be caused by normal cell actions, UV light, some anticancer drugs, and radiation used to treat cancer. Inhibitors of one enzyme, poly (ADP-ribose) polymerase-1, are being studied in the treatment of cancer. Also called PARP.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000725853" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;poly (ADP-ribose) polymerase&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000725852" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;poli-(ADP-ribosa)–polimerasa&quot;" language="es" id="_4"/>
  <SpanishTermName>poli-(ADP-ribosa)–polimerasa</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Tipo de enzima que participa en muchas funciones celulares, incluso el reparo del daño al ADN. El daño al ADN se puede deber al funcionamiento normal de las células, la luz UV, algunos medicamentos contra el cáncer y la radiación que se usa para tratar el  cáncer.    Los inhibidores de una enzima, poli-(ADP-ribosa)–polimerasa-1,   están en estudio para el tratamiento de cáncer. También se llama PARP y poli-adenosina-difosfato-ribosa–polimerasa.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2009-12-01</DateFirstPublished>
  <DateLastModified>2009-12-04</DateLastModified>
</GlossaryTerm>
